DNLI
Price
$13.95
Change
+$0.52 (+3.87%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
1.96B
34 days until earnings call
NUVB
Price
$3.20
Change
+$0.19 (+6.31%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
1.03B
40 days until earnings call
Interact to see
Advertisement

DNLI vs NUVB

Header iconDNLI vs NUVB Comparison
Open Charts DNLI vs NUVBBanner chart's image
Denali Therapeutics
Price$13.95
Change+$0.52 (+3.87%)
Volume$40.57K
Capitalization1.96B
Nuvation Bio
Price$3.20
Change+$0.19 (+6.31%)
Volume$24.77K
Capitalization1.03B
DNLI vs NUVB Comparison Chart in %
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. NUVB commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and NUVB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (DNLI: $13.95 vs. NUVB: $3.20)
Brand notoriety: DNLI and NUVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 62% vs. NUVB: 42%
Market capitalization -- DNLI: $1.96B vs. NUVB: $1.03B
DNLI [@Biotechnology] is valued at $1.96B. NUVB’s [@Biotechnology] market capitalization is $1.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileNUVB’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • NUVB’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVB is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 5 TA indicator(s) are bullish while NUVB’s TA Score has 5 bullish TA indicator(s).

  • DNLI’s TA Score: 5 bullish, 5 bearish.
  • NUVB’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NUVB is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а +9.41% price change this week, while NUVB (@Biotechnology) price change was -0.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

DNLI is expected to report earnings on Oct 30, 2025.

NUVB is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($1.96B) has a higher market cap than NUVB($1.03B). NUVB YTD gains are higher at: 20.301 vs. DNLI (-34.102). NUVB has higher annual earnings (EBITDA): -201.17M vs. DNLI (-521.52M). DNLI has more cash in the bank: 899M vs. NUVB (608M). DNLI has less debt than NUVB: DNLI (46.6M) vs NUVB (57.8M). NUVB has higher revenues than DNLI: NUVB (14.4M) vs DNLI (0).
DNLINUVBDNLI / NUVB
Capitalization1.96B1.03B191%
EBITDA-521.52M-201.17M259%
Gain YTD-34.10220.301-168%
P/E RatioN/AN/A-
Revenue014.4M-
Total Cash899M608M148%
Total Debt46.6M57.8M81%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLINUVB
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 19 days ago
77%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VCSAX104.82N/A
N/A
Vanguard Consumer Staples Index Admiral
EIDIX18.51N/A
N/A
Eaton Vance Global Equity Income I
SAOAX30.57N/A
N/A
NAA Opportunity A
MNDJX29.75N/A
N/A
MFS New Discovery R4
SPEDX22.34N/A
N/A
Alger Dynamic Opportunities A

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with NRIX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-0.37%
NRIX - DNLI
59%
Loosely correlated
-4.25%
OCUL - DNLI
54%
Loosely correlated
-2.55%
RGNX - DNLI
54%
Loosely correlated
-1.89%
BEAM - DNLI
54%
Loosely correlated
-2.12%
IMVT - DNLI
54%
Loosely correlated
+1.36%
More

NUVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with BEAM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
+6.31%
BEAM - NUVB
48%
Loosely correlated
-0.48%
DNLI - NUVB
47%
Loosely correlated
+3.87%
RCUS - NUVB
46%
Loosely correlated
+3.88%
XNCR - NUVB
45%
Loosely correlated
+12.00%
OCUL - NUVB
44%
Loosely correlated
+2.33%
More